SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.
Chiva L, Ordas P, Mishra J, Ayhan A, Lee YY, Bogani G, Sp S, Lomnytska M, Stukan M, Fruscio R, Chura BF, Salcedo-Hernandez RA, De Iaco P, Haidopoulos D, Svintsitskiy V, Jain V, Stanciu P, Rawert FL, Akdemir C, Abdallah R, Chacon E, Minguez JA, Gil-Moreno A, Kharchenko K, Mofrad MH, Gebauer G, Díaz-Feijoo B, Scibilia G, Klaric M, Škof E, Saadeh FA, Mueller MD, Saarelainen S, Tejerizo García Á, Fotopoulou C, Coronado P, Dermikiran F, Goffin F, Tsolakidis D, Gonzalez-Martin A; SUROVA Study Group.
Chiva L, et al. Among authors: jain v.
Int J Gynecol Cancer. 2025 Dec;35(12):102688. doi: 10.1016/j.ijgc.2025.102688.
Int J Gynecol Cancer. 2025.
PMID: 41352872